CLINICAL_TRIALS
research
· 2026-04-15
Clinical Trial Update: Efficacy and Safety of 14-Day Vonoprazan-Based Dual Therapy Versus Quadruple Therapy for Helicobacter Pylori Eradication: A Multicentre, Non-Inferiority Randomized Controlled Trial [NA]
Summary
A multicentre non-inferiority randomized trial compares 14-day vonoprazan-based dual therapy to quadruple therapy for Helicobacter pylori eradication; recruitme…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Yanqing Li | Conditions: HELICOBACTER PYLORI INFECTIONS | NA | Status: RECRUITING